National Breast Cancer and Lymphedema Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01580800|
Recruitment Status : Suspended (Low enrollment and follow-up participation)
First Posted : April 19, 2012
Last Update Posted : March 2, 2018
|Condition or disease|
|Breast Cancer Lymphedema|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||National Breast Cancer and Lymphedema Registry|
|Study Start Date :||September 2011|
|Estimated Primary Completion Date :||September 2021|
|Estimated Study Completion Date :||December 2025|
Breast cancer survivors
Patients who have undergone breast cancer treatment (e.g. surgery, node dissection, chemotherapy and/or radiation therapy), and what affect this has had on their arm health.
- Preemptive diagnostic and treatment strategies [ Time Frame: Each enrolled patient will be followed for an average of 1 year ]The methods for lymphedema surveillance and detection will be correlated to the new appearance of lymphedema in this cohort of breast cancer survivors. We will also assess severity of lymphedema and responsiveness to treatment strategies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01580800
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
|Principal Investigator:||Stanley G Rockson||Stanford University|